Our team has found that patients on concurrent GLP-1 therapy (semaglutide, tirzepatide) often benefit from twice-weekly lipo c dosage during the first 812 weeks of treatment, when caloric deficit is steepest and hepatic fat mobilisation is most active
The prescribing information lists breastfeeding as a time to avoid semaglutide or to make a decision between breastfeeding and taking medication based on the importance of the medication to the mother and potential unknown risks to the infant
Research reviews also describe BPC-157s protective effects in models involving NSAID-related gastrointestinal lesions, alcohol-related injury, perforated stomach lesions, esophagitis, fistula healing, intestinal inflammation, and other GI injury models
It shields skin cells from damage while simultaneously supporting the cellular processes that maintain hydration, promote collagen synthesis, and contribute to overall skin vitality